Effect of melatonin supplementation and cross-fostering on renal glutathione system and development of hypertension in spontaneously hypertensive rats
- 23 August 2013
- journal article
- research article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 70 (1) , 73-79
Abstract
Antenatal and postnatal environments are hypothesised to influence the development of hypertension. This study investigates the synergistic effect of cross-fostering and melatonin supplementation on the development of hypertension and renal glutathione system in spontaneously hypertensive rats (SHR). In one experiment, 1-day-old male SHR pups were fostered to either SHR (shr-SHR) or Wistar-Kyoto rats, (shr-WKY). In a concurrent experiment, SHR dams were given melatonin in drinking water (10 mg/kg body weight) from day 1 of pregnancy. Immediately following delivery, 1-day-old male pups were fostered either to SHR (Mel-shr-SHR) or WKY (Mel-shr-WKY) dams receiving melatonin supplementation until weaning on day 21. Upon weaning, melatonin supplementation was continued to these pups until the age of 16 weeks. Systolic blood pressures (SBP) were recorded at the age of 4, 6, 8, 12 and 16 weeks. Renal antioxidant activities were measured. Mean SBP of shr-WKY, Mel-shr-SHR and Mel-shr-WKY was significantly lower than that in shr-SHR until the age of 8 weeks. At 12 and 16 weeks of age, mean SBP of Mel-shr-WKY was lower than those in non-treated shr-SHR and shr-WKY pups but was not significantly different from that in Mel-shr-SHR. Renal glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities were significantly higher in Mel-shr-SHR and Mel-shr-WKY at 16 weeks of age. It appears that combination of cross-fostering and melatonin supplementation exerts no synergistic effect on delaying the rise in blood pressure in SHR. The elevated GPx and GST activities are likely to be due to the effect of melatonin supplementation.Keywords
This publication has 27 references indexed in Scilit:
- Renal and vascular glutathione S-transferase μ is not affected by pharmacological intervention to reduce systolic blood pressureJournal Of Hypertension, 2009
- Developmental programming and hypertensionCurrent Opinion in Nephrology and Hypertension, 2009
- Glutathione S-transferase variants and hypertensionJournal Of Hypertension, 2008
- Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II–Induced Vascular DysfunctionHypertension, 2008
- Assessment of DNA Oxidation and Antioxidant Activity in Hypertensive Patients with Chronic Kidney DiseaseRenal Failure, 2008
- Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient MiceCirculation, 2007
- RELATIVE CONTRIBUTION OF THE PRENATAL VERSUS POSTNATAL PERIOD ON DEVELOPMENT OF HYPERTENSION AND GROWTH RATE OF THE SPONTANEOUSLY HYPERTENSIVE RATClinical and Experimental Pharmacology and Physiology, 2006
- Maternal nursing behaviour and the delivery of milk to the neonatal spontaneously hypertensive ratActa Physiologica Scandinavica, 1998
- Antioxidant Enzymes - Superoxide Dismutase and Glutathione Peroxidase - in Haemodialyzed PatientsBlood Purification, 1996
- DEVELOPMENT OF HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS: ROLE OF MILK ELECTROLYTESClinical and Experimental Pharmacology and Physiology, 1995